SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-18-224755
Filing Date
2018-07-24
Accepted
2018-07-24 16:40:04
Documents
2
Group Members
AMIN NATHOOANSON ADVISORS INC.ANSON MANAGEMENT GP LLCBRUCE R. WINSONMOEZ KASSAM

Document Format Files

Seq Description Document Type Size
1 SC 13G d542320dsc13g.htm SC 13G 114873
2 EX-99.1 d542320dex991.htm EX-99.1 8355
  Complete submission text file 0001193125-18-224755.txt   125006
Mailing Address 5950 BERKSHIRE LANE SUITE 210 DALLAS TX 75225
Business Address 5950 BERKSHIRE LANE SUITE 210 DALLAS TX 75225 214.866.0202
Anson Funds Management LP (Filed by) CIK: 0001491072 (see all company filings)

IRS No.: 300134498 | State of Incorp.: TX | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837
Business Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837 732-902-4000
ContraVir Pharmaceuticals, Inc. (Subject) CIK: 0001583771 (see all company filings)

IRS No.: 462783806 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-87637 | Film No.: 18966858
SIC: 2834 Pharmaceutical Preparations